A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.

Source:http://linkedlifedata.com/resource/pubmed/id/19410624

Vaccine 2009 Jun 24 27 31 4104-9

Download in:

View as

Triples

General Info

PMID
19410624